The Venus Times

Publications

AMR in Focus: Mr Saransh Chaudhary’s Insights Across Media

Mr Saransh Chaudhary explores how antimicrobial innovation must move beyond conventional antibiotic discovery, highlighting safer drug design, translational research, targeted delivery and stronger innovation ecosystems.

Accreditations & Approvals

Six New Milestones on Our Global Journey

Venus Remedies secured 6 new Marketing Authorizations across Africa and Latin America, expanding its presence in oncology, anti-infective and critical-care therapies

Engagements

Mr Akshansh Chaudhary Takes the Stage at ET Smart Factory Summit 2026

Akshansh Chaudhary represented Venus Remedies at the ET Smart Factory Summit 2026, sharing insights on responsible AI adoption in pharmaceutical manufacturing.

Events

EPL 2026: Celebrating Performance That Stands Out

EPL 2026 celebrated the outstanding performance, initiative, and commitment of teams across Venus Remedies.

Accreditations & Approvals

Expanding Our Presence in Georgia with Gemcitabine

Venus Remedies Limited has received MA for Gemcitabine in Georgia, marking another milestone in its global expansion.

Engagements

Mr Saransh Chaudhary Joins Forbes India’s Chandigarh Blueprint

Mr Saransh Chaudhary, ED & CEO, Venus Medicine Research Centre, joined Forbes India’s Chandigarh Blueprint to discuss the Tricity’s growing role in life sciences.

Publications

Mr Saransh Chaudhary Shares Industry Perspectives Across Leading Editorial Platforms

Mr Saransh Chaudhary shares expert perspectives on India's API ecosystem and AI-driven drug discovery through articles published in Moneycontrol.com and Pharma Focus Asia.

Events

Celebrating Wellness and Collaboration: International Yoga Day & HOD Offsite Meet

Venus Remedies celebrated International Yoga Day across all units, while the HOD Offsite Meet at Morni Hills brought departmental leaders together for leadership development.

Publications

Leadership in Focus: Mr Akshansh Chaudhary Featured by Top Industry Publications

Venus Remedies Executive Director & CTO Akshansh Chaudhary has been featured in OEM Update Magazine and Pharmaphorum for his insights on pharmaceutical automation and the complexities of manufacturing critical care injectables

Accreditations & Approvals

Venus Continues Global Expansion with New Market Approvals

Venus Remedies has secured six new market authorizations across Asia, Africa, and Latin America, expanding its anti-infective and oncology portfolio.

Accreditations & Approvals

Venus Remedies Expands Footprint in Latin America

Venus Remedies has secured its first marketing authorization in Argentina for Ceftriaxone, strengthening its footprint in Latin America.

Publications

Mr. Saransh Chaudhary featured in IndiaMed Today

Mr. Saransh Chaudhary, Executive Director and CEO of VMRC, was featured in IndiaMed Today for his insights on antimicrobial resistance.

Accreditations & Approvals

Venus Remedies Receives Saudi FDA Approval for Plerixafor

Venus Remedies has received Saudi FDA approval for Plerixafor, marking its first global authorization for the specialty oncology drug.

News

A New Chapter in Leadership: Strategic Appointments to Drive Growth and Innovation at Venus Remedies

Venus Remedies enters a new chapter of leadership with the appointment of Mr. Saransh Chaudhary as Executive Director and Dr. Gurminder Singh Bedi as Non-Executive Independent Director.

Events

An Evening of Celebration: PPL Season 10 at Venus

Venus Remedies celebrated PPL Season 10 on the evening of the Respected CMD Sir's birthday. The event honoured winning teams with trophies, cash prizes, and certificates while celebrating teamwork and the company’s culture.

Events

Honouring the Respected CMD Sir’s Vision Through Education Support on His Birthday

Venus Remedies celebrated the birthday of the Respected CMD sir, Mr Pawan Chaudhary, with children’s activities, performances, and an Education Grant. It reflected our commitment to supporting students in their educational journey.

News

Venus Remedies Secures 10 New Market Authorizations

Venus Remedies secures 10 new Market Authorizations across key global markets, strengthening access to injectable therapies in oncology, anti-infectives, critical care, and anticoagulation.

News

Venus Remedies Recognized among the Top 10 Injectable Manufacturer Companies in India

Venus Remedies has been recognized among the Top 10 Injectable Manufacturers in India, reflecting its long-standing focus on quality, safety, and complex injectable therapies.

Events

Venus Celebrates Financial Independence With Mission 2030

With the commitment to build a stronger future for stakeholders and patients worldwide, Venus Remedies begins a new chapter.

Associations

Venus’ Participation in the IAIH Panel Discussion

Venus Remedies joined the IAIH panel discussion at the India AMR Innovation Workshop, highlighting the need to move AMR innovations from research to real-world impact.

Events

Marking 35 Years of Growth and Commitment in Healthcare

Reflecting on our journey of quality healthcare on the occasion of 35th Annual Raising Day.

Accreditations & Approvals

Expanding Global Access: New Market Authorizations for Venus Remedies

Venus Remedies expands global healthcare access with new market authorizations in essential care

Accreditations & Approvals

Strengthening Global Reach: Venus Remedies Unit I & II Approved by the Gabon Authority

Venus Remedies receives Gabon Authority approval for Panchkula and Baddi units, expanding global reach with GMP-compliant manufacturing excellence.

Engagements

Venus Remedies Reinforces Global Vision at World Health Expo Dubai 2026

Venus Remedies showcased its global healthcare vision at the World Health Expo Dubai 2026.

News

How Union Budget 2026 - 27 Accelerates Research-Led Pharmaceutical Growth: Insights by Mr Saransh Chaudhary

Saransh Chaudhary highlights how India’s Union Budget 2026–27 marks a decisive shift toward science-driven pharma growth and stronger healthcare foundations.